| (Values in U.S. Thousands) | Mar, 2026 | Mar, 2026 | Mar, 2026 | Mar, 2026 | Mar, 2026 |
| Sales | 0 | 0 | 0 | 0 | 0 |
| Sales Growth | unch | unch | unch | unch | unch |
| Net Income | 0 | 0 | 0 | 0 | 0 |
| Net Income Growth | unch | unch | unch | unch | unch |
Niusule Bio-Pharmace (NIUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Niusule Bio-Pharmaceutical Corp. formerly Niusule Biotech Corp. is a Nevada corporation formed on April 8, 2008. It is a bio-pharmaceutical company dedicated to enhance both human (children) and animal health. The Company caters to China's rapidly growing demand for safe and products. For the human line, Niusule currently has a retail distribution network throughout China comprised of 124 outlets at high-end supermarkets and shopping malls in Zhejiang province, Shanghai and Beijing. The Company is aggressively seeking to expand into other regions. Regarding animal health, through the Company's affiliate, Niusule Behigh (Tianjin ) Pharmaceutical Group Co., Ltd, the Company has acquired the veterinary drugs and feed additives manufacturing license issued by China's Ministry of Agriculture and has 183 products.Niusule Behigh (Tianjin ) Pharmaceutical Group Co., Ltd has 10 Good Manufacturing Practice (GMP) production lines certified by the China's Ministry of Agriculture for small volume injection, tablets, granules, oral solutions, powder, pelvis, disinfectant, and purring.